November 14, 2025
  • Facebook
  • Twitter
  • LinkedIn

BiomolBiomed Viewpoints

Science in plain words

  • Home
  • News
  • About
    • BiomolBiomed Viewpoints
    • BiomolBiomed Journal
  • Journal Website
  • Reviews
  • pathology
  • microbiology
  • immunology
  • translational medicine
  • genetics
  • biochemistry
  • anatomy
  • molecular biology
  • clinical medicine
  • new methods
  • new medical entities
Latest posts
  • [ November 12, 2025 ] Neuroprotective Effects of Melatonin and Omega-3 Against Prenatal Electromagnetic Field Exposure Author Summary
  • [ November 11, 2025 ] The Reviewer of the Month for November 2025: Maja Jazvinšćak Jembrek, PhD Reviewer of the Month
  • [ November 10, 2025 ] Predictive Inflammatory Markers in Inguinal Hernia Surgery: General vs Spinal Anesthesia Author Summary
  • [ November 7, 2025 ] Distinct EMT Marker Changes Across Glioma Subtypes Author Summary
  • [ November 5, 2025 ] Beyond BMI: AI-Powered CT Body Composition Author Summary
Homemyeloma cell line

myeloma cell line

NAMPT and LYST as potential therapeutic targets in multiple myeloma
Author Summary

NAMPT and LYST as potential therapeutic targets in multiple myeloma

August 8, 2017 0

Multiple myeloma (MM) is a type of blood cancer that affects the plasma cell. It is a rare form of cancer, accounting for 1% of all cancer diagnoses and 2% of all cancer deaths. The […]

BiomolBiomed journal metrics

  • Impact Factor 2024 (JCR®): 2.2
  • CiteScore 2024 (Scopus): 5.2
  • Google Scholar Citations
  • Dimensions metrics

See more here…

BiomolBiomed Newsletters

Subscribe to receive the latest content and news from Biomolecules and Biomedicine. Choose from our sections or themes of your interest.

Categories

  • Author Summary
  • Conferences
  • Interview
  • News
  • Opinion
  • Reviewer of the Month
  • Topics
  • Video Summary

Archives

TELL US

What matters the most when choosing the journal to submit your article?
Vote
Follow us on Facebook

Copyright (c) 2021 Association of Basic Medical Sciences of FBIH

 

Loading Comments...